Enter your email address to receive updates
Search By Trade Name
Trade name | Generic name | Classification
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z 
Generic Name
Immune gobulin intravenous, (IGIV; IVIG).
Trade Name
Iveegam
Risk Category
C
  • Studies on animals show adverse effect and toxicity on fetus.
  • No adequate and well controlled studies done on pregnant women.
  • Drugs should be given only if the potential benefit outweighs the potential risk to the fetus.
FDA Pregnancy Risk Categories

Place (not click) your mouse cursor over the bold words in the text below to receive description

Indication
Indication
  • serum, human immunoglobulin mainly G(IgG) for intravenous infusion for hypogammaglobulinemia, immune thrombocytopenic purpura.
  • Severe Rh-immunization and alloimmune thrombocytopenia. Used also in recurrent abortions caused by antiphospholipid antibodies, in neonatal congenital heart block caused by maternal antibodies to Ro (SS-A) and La (SS-B) autoantigens.
  • Fetal Risk
    Fetal Risk
  • placenta (organ within uterus, which is attached to embryo and walls of uterus)">placental transfer of IgG is dependent on the dose and gestational age and it crosses the placenta in significant amount after 32 weeks gestation.
  • No fetal adverse effects reported.
  • Breast Feeding
    Breast Feeding
  • No data available.
  • Other Trade Names
     
    The information on this Web site is not intended as a substitute for the advice and care of your doctor or other health-care provider. Always consult your doctor if you have any questions about exposures during pregnancy and lactation, and before you take any medications. Please read the Terms and Conditions before using this website.
      Tell A Friend

        You
    Name
    Email
        Your Friend
    Name
    Email
        Comments
     8   +   1    =  
      Calculate Birth Date
    Enter the first day of the last menstruation
    Month Day Year
    Result
    Month Day Year